Avet recalls tetracycline antibiotic capsules on low-potency fears

Antibiotic-resistant bacteria
Avet will pull its tetracycline capsules off U.S. shelves on low dissolution concerns. (Getty)

For patients taking generic antibiotics, adequate potency levels can mean the difference between a quick recovery and a trip to the hospital. But what happens if that potency isn't up to snuff? Manufacturer Avet Pharmaceuticals doesn't want to find out.

RELATED: Pfizer, Mylan say COVID-19 delays will postpone their Viatris merger

Avet has issued a voluntary nationwide recall of tetracycline antibiotic capsules marketed under the Heritage Pharmaceuticals brand because of low dissolution levels.

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.

The recalled lots of 250- and 500-milligram capsules were distributed between August and March, the FDA said. So far, the drugmaker has not received any adverse event reports or complaints.

The FDA warned that low levels of dissolution in the body could limit the drug's ability to fight off serious infections like pneumonia, potentially leading to the progression of the infection or death.

RELATED: Amneal yanks ulcer drug off U.S. shelves on fears of carcinogen contamination